Trametinib Inhibits the Growth and Aerobic Glycolysis of Glioma Cells by Targeting the PKM2/c-Myc AxisMingjun Gao, Jing Liu|Frontiers in Pharmacology|2021Cited by 38
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Xiaofeng Zeng, Shangzhu Zhang et al.|Annals of the Rheumatic Diseases|2025Cited by 17